Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases

• Main Authors: Burcu Bozkaya Yücel (Author), Ozlem Aydog (Author), Hulya Nalcacioglu (Author), Ayşegül Yılmaz (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Anti-interleukin 1 agents are used successfully in colchicine-resistant or intolerant Familial Mediterranean Fever (FMF) patients. Sixty-five patients with FMF who received canakinumab treatment for at least 6 months due to colchicine resistance or intolerance between 2016 and 2020 in our department...